{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:31:41Z","timestamp":1777552301107,"version":"3.51.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/fpc.0000000000000230","type":"journal-article","created":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T14:25:23Z","timestamp":1463754323000},"page":"414-422","source":"Crossref","is-referenced-by-count":22,"title":["Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis"],"prefix":"10.1097","volume":"26","author":[{"given":"Camilla","family":"Stephens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agustin","family":"Castiella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva M.","family":"Gomez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Otazua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel-\u00c1ngel","family":"L\u00f3pez-Nevot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Ortega-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ruiz-Cabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Medina-C\u00e1liz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Robles-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hacibe","family":"Hallal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Moreno-Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210213","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R2-2-20210213","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoinmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R3-2-20210213","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"R4-2-20210213","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","author":"Muratori","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-2-20210213","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000070","article-title":"Mechanisms of drug-induced liver injury","volume":"14","author":"Stephens","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s10620-015-3708-7","article-title":"Transitioning from idiopathic to explainable autoimmune hepatitis","volume":"60","author":"Czaja","year":"2015","journal-title":"Dig Dis Sci"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"R8-2-20210213","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"R9-2-20210213","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.12.019","article-title":"Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis","volume":"42","author":"Yoshizawa","year":"2005","journal-title":"J Hepatol"},{"key":"R10-2-20210213","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1440-1746.2003.02918.x","article-title":"Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type 1 in Chinese patients","volume":"18","author":"Qiu","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R11-2-20210213","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1478-3231.2007.01581.x","article-title":"Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela","volume":"27","author":"Fortes","year":"2007","journal-title":"Liver Int"},{"key":"R12-2-20210213","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","article-title":"Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition","volume":"30","author":"Pando","year":"1999","journal-title":"Hepatology"},{"key":"R13-2-20210213","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","article-title":"Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2","volume":"94","author":"Bittencourt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin\u2013clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"R15-2-20210213","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"R16-2-20210213","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury","volume":"42","author":"Singer","year":"2010","journal-title":"Nat Genet"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","article-title":"Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis","volume":"8","author":"Kindmark","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"R18-2-20210213","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/tpj.2015.40","article-title":"Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01","volume":"16","author":"Parham","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"R19-2-20210213","doi-asserted-by":"crossref","first-page":"e68111","DOI":"10.1371\/journal.pone.0068111","article-title":"HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity","volume":"8","author":"Stephens","year":"2013","journal-title":"PLoS One"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1","volume":"16","author":"van Gerven","year":"2015","journal-title":"Genes Immun"},{"key":"R21-2-20210213","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"B\u00e9nichou","year":"1990","journal-title":"J Hepatol"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4254\/wjh.v6.i4.160","article-title":"Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease","volume":"6","author":"Castiella","year":"2014","journal-title":"World J Hepatol"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol"},{"key":"R26-2-20210213","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.4049\/jimmunol.174.11.7085","article-title":"In silico identification of supertypes for class II MHCs","volume":"174","author":"Doytchinova","year":"2005","journal-title":"J Immunol"},{"key":"R27-2-20210213","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3748\/wjg.v11.i12.1862","article-title":"Genetic distinctions between autoimmune hepatitis in Italy and North America","volume":"11","author":"Muratori","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0168-8278(97)80106-7","article-title":"Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens","volume":"26","author":"Jurado","year":"1997","journal-title":"J Hepatol"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2337\/db05-1276","article-title":"Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype","volume":"55","author":"Aly","year":"2006","journal-title":"Diabetes"},{"key":"R30-2-20210213","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1568-9972(01)00004-0","article-title":"Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions","volume":"1","author":"Candore","year":"2002","journal-title":"Autoimmun Rev"},{"key":"R31-2-20210213","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1196\/annals.1386.003","article-title":"Genetic control of immune response in carriers of ancestral haplotype 8.1: the study of chemotaxis","volume":"1089","author":"Candore","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"e1001323","DOI":"10.1371\/journal.pgen.1001323","article-title":"Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production","volume":"7","author":"Chung","year":"2011","journal-title":"PLoS Genet"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immun"},{"key":"R35-2-20210213","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cgh.2007.12.048","article-title":"Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis","volume":"6","author":"Czaja","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R36-2-20210213","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar3271","article-title":"Risk factors for ANA positivity in healthy persons","volume":"13","author":"Li","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R38-2-20210213","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1196\/annals.1422.061","article-title":"Autoantibodies in nonautoimmune individuals during infections","volume":"1108","author":"Berlin","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"R39-2-20210213","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:23:25Z","timestamp":1620951805000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201609000-00002"}},"subtitle":["the influence of human leucocyte antigen alleles"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000230","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}